ASMB NASDAQ
Assembly Biosciences, Inc.
1W: -4.8%
1M: -38.6%
3M: -22.0%
YTD: -33.2%
1Y: -8.4%
3Y: +113.5%
5Y: -44.3%
$22.54
-0.44 (-1.91%)
Weekly Expected Move ±6.8%
$19
$21
$23
$24
$26
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-08-07
Earliest Filing
2025-08-11
Latest Filing
partner: 8
investor: 2
Counterparties (Filed by ASMB)
10 relationshipsCompanies named in ASMB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Gilead Sciences | GILD | investor | Investor in the private placement of common stock and warrants. | 2025-08-11 | View |
| Arsenal Biosciences, Inc. | — | partner | Sublessor in a sublease amendment agreement | 2025-01-03 | View |
| AP3-SF3 CT NORTH, LLC | — | partner | Master Lessor in the underlying lease agreement | 2025-01-03 | View |
| GNS NORTH TOWER, L.P. | — | partner | Predecessor in interest to the Master Lessor | 2025-01-03 | View |
| Gilead Sciences, Inc. | GILD | partner | Partner in an amended option, license, and collaboration agreement involving restructuring of fees and an upfront paymen | 2024-12-19 | View |
| Jefferies LLC | JEF | partner | Sales agent for the Company's at-the-market offering program. | 2024-11-07 | View |
| Gilead Sciences, Inc. | GILD | investor | Purchased 179,500 shares of common stock and warrants in a private placement and amended existing equity agreements. | 2024-06-18 | View |
| Gilead Sciences, Inc. | GILD | partner | Entered into an Option, License and Collaboration Agreement and equity investment agreements for exclusive licensing of | 2023-10-17 | View |
| Arsenal Biosciences, Inc. | — | partner | Entered into a sublease agreement for office and laboratory space. | 2023-08-07 | View |
| GNS North Tower, L.P. | — | partner | Master Lessor providing consent for the sublease. | 2023-08-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-08-13 | Acquisition/Disposition; Exhibits | Acquisition | View |
| 2026-06-05 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-26 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Officer/Director Change; Exhibits | View | |
| 2025-12-08 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-11 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-08-08 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-25 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-09 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-01-03 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2024-12-26 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-19 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR